Crescent Biopharma, Inc. (CBIO)

11.85 -0.37 (-3.03%) USD  |  NASDAQ  |  Dec 19, 16:00
11.88 +0.03 (+0.25%) After-Hours: 20:00
More

Price Chart

Key Stats

View All Stats
Price and Performance
Market Cap 164.63M
52 Week High (Daily) Upgrade
52 Week Low (Daily) Upgrade
All-Time High (Daily) Upgrade
Year to Date Total Returns (Daily) Upgrade
1 Month Total Returns (Daily) Upgrade
1 Year Total Returns (Daily) -42.34%
Valuation
PE Ratio --
PE Ratio (Forward) Upgrade
PS Ratio --
Price to Book Value 1.462
EV to EBITDA Upgrade
Dividend
Dividend --
Dividend Yield (Forward) Upgrade
Financials
Revenue (5 Year Growth) Upgrade
Revenue (Quarterly YoY Growth) Upgrade
EPS Diluted (5 Year Growth) Upgrade
EPS Diluted (Quarterly YoY Growth) Upgrade
Debt to Equity Ratio 0.0149
Return on Equity Upgrade
Return on Assets Upgrade
Risk
Beta (5Y) Upgrade
Max Drawdown (5Y) 98.15%

Ratings

Y-Rating Upgrade
Value Score Upgrade
Fundamental Score Upgrade
Valuation (Hist. Mult.) Upgrade

Profile

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.
URL http://www.crescentbiopharma.com
Investor Relations URL N/A
HQ State/Province Massachusetts
Sector  
Industry  
Next Earnings Release N/A
Last Earnings Release Aug. 02, 2018
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ratings

Y-Rating Upgrade
Value Score Upgrade
Fundamental Score Upgrade
Valuation (Hist. Mult.) Upgrade

Profile

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.
URL http://www.crescentbiopharma.com
Investor Relations URL N/A
HQ State/Province Massachusetts
Sector  
Industry  
Next Earnings Release N/A
Last Earnings Release Aug. 02, 2018
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A